Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background and Purpose</h3>Pyroptosis is a lytic form of proinflammatory cell death characterised as caspase‐1‐dependent with canonical NLRP3 inflammasome‐induced gasdermin D (GSDMD) activation. We aimed to investigate the role of acinar pyroptotic cell death in pancreatic injury and systemic inflammation in acute pancreatitis (AP).</section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Experimental Approach</h3>Pancreatic acinar pyroptotic cell death pathway activation upon pancreatic toxin stimulation in vitro and in vivo were investigated. Effects of pharmacological (NLRP3 and caspase‐1 inhibitors), constitutive (Nlrp3‐/‐, Caspase‐1‐/‐ and Gsdmd‐/‐) and acinar cell conditional (Pdx1CreNlrp3Δ/Δ and Pdx1CreGsdmdΔ/Δ) genetic inhibition on pyroptotic acinar cell death, pancreatic necrosis and systemic inflammation were assessed using mouse AP models (caerulein, sodium taurocholate, L‐arginine). Effects of Pdx1CreGsdmdΔ/Δ vs myeloid conditional knockout (Lyz2CreGsdmdΔ/Δ) and Gsdmd‐/‐ vs receptor interacting protein 3 (RIP3) inhibitor were compared in caerulein‐induced AP (CER‐AP). </section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Key Results</h3>There was consistent pyroptotic acinar cell death upon pancreatic toxin stimulation both in vitro and in vivo which was significantly reduced by pharmacological or genetic pyroptosis inhibition. Pdx1CreGsdmdΔ/Δ but not Lyz2CreGsdmdΔ/Δ mice significantly reduced pyroptotic acinar cell death, pancreatic necrosis and systemic inflammation in CER‐AP. Co‐application of RIP3 inhibitor on Gsdmd‐/‐ mice further increased protection on CER‐AP. </section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion and Implications</h3>This work demonstrates a critical role for NLRP3 inflammasome and GSDMD activation‐mediated pyroptosis in acinar cells, linking pancreatic necrosis and systemic inflammation in AP. Targeting pyroptosis signalling pathways holds promise for specific AP therapy.</section>

Author Correction: Inhibition of RIPK1-dependent regulated acinar cell necrosis provides protection against acute pancreatitis via the RIPK1/NF-κB/AQP8 pathway

Inhibition Of Hypoxia-Inducible Factor-1 Alpha Alleviates Acinar Cell Necrosis In A Mouse Model Of Acute Pancreatitis

Protective Effects of Necrostatin-1 in Acute Pancreatitis: Partial Involvement of Receptor Interacting Protein Kinase 1

RETRACTED: Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes Dis DOI: 10.1016/J.gendis.2020.07.005]

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

NQDI-1 Protects Against Acinar Cell Necrosis in Three Experimental Mouse Models of Acute Pancreatitis.

Corrigendum: Clostridium butyricum protects against pancreatic and intestinal injury after severe acute pancreatitis via downregulation of MMP9

Hypoxia-Inducible Factor-1α Knockdown Plus Glutamine Supplementation Attenuates the Predominance of Necrosis over Apoptosis by Relieving Cellular Energy Stress in Acute Pancreatitis

[Corrigendum] FKBP11 protects intestinal epithelial cells against inflammation‐induced apoptosis via the JNK‐caspase pathway in Crohn's disease

Correction to: Inhibition of Dectin-1 Ameliorates Neuroinflammation by Regulating Microglia/Macrophage Phenotype After Intracerebral Hemorrhage in Mice

IDH2-NADPH pathway protects against acute pancreatitis via suppressing acinar cell ferroptosis

Acinar cell NLRP3 inflammasome and gasdermin D (GSDMD) activation mediates pyroptosis and systemic inflammation in acute pancreatitis

Dichotomy Between Receptor-Interacting Protein 1– and Receptor-Interacting Protein 3–mediated Necroptosis in Experimental Pancreatitis

Disulfiram reduces the severity of mouse acute pancreatitis by inhibiting RIPK1-dependent acinar cell necrosis

Corrigendum: Receptor of advanced glycation end products deficiency attenuates cisplatin-induced acute nephrotoxicity by inhibiting apoptosis, inflammation and restoring fatty acid oxidation

Corrigendum to “ethyl Pyruvate Ameliorates Hepatic Ischemia-Reperfusion Injury by Inhibiting Intrinsic Pathway of Apoptosis and Autophagy”

Inhibition of xanthine oxidase alleviated pancreatic necrosis via HIF-1 α-regulated LDHA and NLRP3 signaling pathway in acute pancreatitis

Activation of AMPK restored impaired autophagy and inhibited inflammation reaction by up-regulating SIRT1 in acute pancreatitis

Inhibition of aquaporin-9 ameliorates severe acute pancreatitis and associated lung injury by NLRP3 and Nrf2/HO-1 pathways

Author Correction: Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy

Corrigendum to “maggot Extracts Alleviate Inflammation and Oxidative Stress in Acute Experimental Colitis Via the Activation of Nrf2”